BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201123T120000
DTEND;TZID=America/New_York:20201123T123000
DTSTAMP:20260406T084043
CREATED:20201014T154733Z
LAST-MODIFIED:20201014T154733Z
UID:12497-1606132800-1606134600@www.masslifesciences.com
SUMMARY:Emerging Business Models in Digital Health
DESCRIPTION:In this Harvard Medical School webinar\, Bill Evans\, CEO & Managing Director of Rock Health\, will examine emerging business models and the state of digital health in a very dynamic clinical\, reimbursement and regulatory environment. Amidst the coronavirus pandemic\, adoption of digital tools has accelerated with use cases expanding across the health care industry (including health systems\, payers and biopharma and devices companies). FDA approvals for digital therapeutics and the $38 billion Teladoc-Livongo merger represent significant milestones in the maturation of the digital health sector.
URL:https://www.masslifesciences.com/event/emerging-business-models-in-digital-health/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201109T110000
DTEND;TZID=America/New_York:20201120T160000
DTSTAMP:20260406T084043
CREATED:20200917T133254Z
LAST-MODIFIED:20200917T133254Z
UID:12381-1604919600-1605888000@www.masslifesciences.com
SUMMARY:Leading Digital Transformation in Health Care
DESCRIPTION:This Harvard Medical Schoolo open enrollment online program provides you with the knowledge\, tools and strategies to design and implement technology-enabled change initiatives in health care. It will feature a combination of live virtual class sessions and self-paced learning and discussions. A certificate of completion will be provided.
URL:https://www.masslifesciences.com/event/leading-digital-transformation-in-health-care-2/2020-11-09/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201020T120000
DTEND;TZID=America/New_York:20201020T123000
DTSTAMP:20260406T084043
CREATED:20200827T141052Z
LAST-MODIFIED:20200827T141052Z
UID:12280-1603195200-1603197000@www.masslifesciences.com
SUMMARY:A Technologist's Journey Through Medicine
DESCRIPTION:In this Harvard Medical School webinar\, Prem Ramaswami\, Head of Product at Sidewalk Labs\, an Alphabet company focused on increasing the sustainability and affordability of cities discusses when in the early days of COVID\, he worked closely with Boston Children’s Hospital and Harvard Health Map to bring together a group of tech company volunteers to launch CovidNearYou.org\, a crowd-sourced surveillance app. Previously\, Prem led Google Search’s efforts around Social Impact including Health\, Civics\, Education\, Crisis Response\, and Social Good. While he was at Google\, Prem helped develop and attended the first cohort of HMS’s Executive Education program for Google.
URL:https://www.masslifesciences.com/event/a-technologists-journey-through-medicine/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200902T120000
DTEND;TZID=America/New_York:20200902T123000
DTSTAMP:20260406T084043
CREATED:20200722T123744Z
LAST-MODIFIED:20200722T123744Z
UID:12075-1599048000-1599049800@www.masslifesciences.com
SUMMARY:A Framework for Digital Transformation in Health Care
DESCRIPTION:John Glaser\, PhD\, has led efforts to use digital platforms to improve health care delivery in many different contexts: as a senior advisor to the federal government\, CIO of a large academic health system\, CEO of Siemens Health Services\, and SVP and executive senior advisor at Cerner. In this webinar\, he will discuss lessons learned from these experiences\, from data and digital platforms to organizational processes and business models.
URL:https://www.masslifesciences.com/event/a-framework-for-digital-transformation-in-health-care/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200824T120000
DTEND;TZID=America/New_York:20200824T123000
DTSTAMP:20260406T084043
CREATED:20200804T200203Z
LAST-MODIFIED:20200806T132355Z
UID:12113-1598270400-1598272200@www.masslifesciences.com
SUMMARY:Social Medicine and Health Care Technology Innovation
DESCRIPTION:In this Harvard Medical School webinar\, Dr. James will discuss the need for change given the inequalities and disparities in health care. He will also discuss the rationale for extending care beyond the walls of the hospital and into communities\, the powerful influence of social determinants of health on patient outcomes\, and how physicians can be effective agents of social change.
URL:https://www.masslifesciences.com/event/social-medicine-physicians-as-agents-of-change/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200818T080000
DTEND;TZID=America/New_York:20200818T170000
DTSTAMP:20260406T084043
CREATED:20200604T140139Z
LAST-MODIFIED:20200604T140139Z
UID:11859-1597737600-1597770000@www.masslifesciences.com
SUMMARY:HMX Pro - Immuno-oncology (Application Deadline)
DESCRIPTION:Join us for an online course that covers topics including tumor immunology\, checkpoint blockade therapy\, CAR T cell therapy\, and more. Applications are due by August 18. Course tuition is $800. \nHMX Pro online courses are designed to help busy professionals get up to speed on the latest advances in medical science. Each course is taught by Harvard Medical School faculty and include detailed animations and illustrations\, real-life scenarios\, and clinical videos that demonstrate the relevance of what you’re learning – with real patient interactions and cutting-edge treatments. Build your science knowledge and learn what’s behind today’s health care innovations – while having the opportunity to earn a certificate from Harvard Medical School. HMX Pro Immunology – Immuno-oncology is an advanced course that covers topics including tumor immunology\, checkpoint blockade therapy\, CAR T cell therapy\, and more. The next course period runs from September 8 – November 20\, 2020. Applications are due by August 18. Individual course tuition is $800.
URL:https://www.masslifesciences.com/event/hmx-pro-immuno-oncology-application-deadline/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200722T123000
DTEND;TZID=America/New_York:20200722T130000
DTSTAMP:20260406T084043
CREATED:20200529T133906Z
LAST-MODIFIED:20200529T133906Z
UID:11819-1595421000-1595422800@www.masslifesciences.com
SUMMARY:Harvard Medical School Executive Education Webinar - Digital Health Apps: Evidence\, Reimbursement and Outcomes
DESCRIPTION:Apps for health\, wellness and disease management are increasingly common across the healthcare ecosystem. Health systems\, biotech and pharma\, payers and pharmacy benefits managers are just a few of the industry sectors actively using digital tools to try to improve care delivery and outcomes. \nThis webinar will discuss emerging lessons and concepts from this space. What is the practical significance of the designation “digital therapeutic?” What are the current regulatory pathways? How does reimbursement actually work? Megan Jones Bell\, MD\, Chief Science Officer for Headspace\, will discuss examples of how these interventions are being integrated into health care and some of the developments on the horizon for this industry.
URL:https://www.masslifesciences.com/event/harvard-medical-school-executive-education-webinar-digital-health-apps-evidence-reimbursement-and-outcomes/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200617T110000
DTEND;TZID=America/New_York:20200617T113000
DTSTAMP:20260406T084043
CREATED:20200529T133728Z
LAST-MODIFIED:20200529T133728Z
UID:11822-1592391600-1592393400@www.masslifesciences.com
SUMMARY:Harvard Medical School Executive Education Webinar - Understanding the AI Development Pipeline in Health Care
DESCRIPTION:Speaker: Andrew Beam\, PhD\, Assistant Professor of Biomedical Informatics\, Harvard Medical School; Assistant Professor of Epidemiology\, Harvard T.H Chan School of Public Health \nAs applications of AI in health care expand\, leaders must understand what problems benefit most from advanced AI approaches\, the processes that are required to implement an AI strategy\, and its potential harms. This webinar will explore these critical issues through case studies\, and provide a framework to help leaders understand how AI can help their organizations create and capture value in health care.
URL:https://www.masslifesciences.com/event/harvard-medical-school-executive-education-webinar-understanding-the-ai-development-pipeline-in-health-care/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200602T090000
DTEND;TZID=America/New_York:20200602T170000
DTSTAMP:20260406T084043
CREATED:20200221T035747Z
LAST-MODIFIED:20200311T211830Z
UID:10506-1591088400-1591117200@www.masslifesciences.com
SUMMARY:Accelerating Biotech and Pharmaceutical R&D through Genomics
DESCRIPTION:There has been increasing interest and investment in applying genomics and related technologies to drug discovery and development. However\, with the exception of a small number of well-recognized successes\, much uncertainty remains about how to best leverage these tools throughout the pharmaceutical value chain. \nThere has been increasing interest and investment in applying genomics and related technologies to drug discovery and development. However\, with the exception of a small number of well-recognized successes\, much uncertainty remains about how to best leverage these tools throughout the pharmaceutical value chain. Led by renowned leaders from industry and academia\, this executive education program provides a unique opportunity to delve into the use of genomics in common and rare diseases\, and throughout the drug discovery\, development\, regulatory and post-regulatory phases. Pre-work\, case-based teaching and group work will ground insights in real-world applications.
URL:https://www.masslifesciences.com/event/accelerating-biotech-and-pharmaceutical-rd-through-genomics/2020-06-02/
LOCATION:Harvard Medical School\, 25 Shattuck St\, Boston\, 02115\, United States
CATEGORIES:Other Upcoming Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200526T123000
DTEND;TZID=America/New_York:20200526T133000
DTSTAMP:20260406T084043
CREATED:20200519T182554Z
LAST-MODIFIED:20200519T182554Z
UID:11780-1590496200-1590499800@www.masslifesciences.com
SUMMARY:Harvard Medical School Executive Education Webinar
DESCRIPTION:Join Harvard Medical School Executive Education for a discussion on Google’s health care activities during COVID-19 and beyond featuring Aashima Gupta\, Director\, Global Health Care Solutions\, Google Cloud and Katherine Chou\, Director of Research & Innovations\, Health and AI for Social Good\, Google.
URL:https://www.masslifesciences.com/event/harvard-medical-school-executive-education-webinar/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200514T090000
DTEND;TZID=America/New_York:20200514T170000
DTSTAMP:20260406T084043
CREATED:20200221T035747Z
LAST-MODIFIED:20200311T211521Z
UID:10504-1589446800-1589475600@www.masslifesciences.com
SUMMARY:Leading Digital Transformation in Health Care
DESCRIPTION:“Leading Digital Transformation in Health Care” is a two-day Harvard Medical School executive education program led by John D. Halamka and designed to provide you with the knowledge\, tools and strategies to design and implement technology-enabled change initiatives in health care. A certificate of completion will be offered for this program. \nDigital health technologies can make it more convenient for a patient to make an appointment. They can make it easier for doctors to access the right information at the right time. They can make it more efficient for a health system to manage their population and deliver high-value\, high-quality care at a reasonable cost—or to continually improve care through knowledge generation in the model of a learning health system. Excitement and investment in these technologies is rapidly increasing. At the same time\, the adoption and value proposition of technology for health care remains complex and multifaceted. Which innovations will provide more cost-effective\, patient-centered\, quality care? How do you differentiate value-producing technologies from hype? As a leader\, what are the critical steps in managing the change process? How do you leverage digital strategies throughout your organization to benefit all aspects of health care? Insights into these questions are critical not just for health systems\, but also business leaders developing industry solutions for health care. “Leading Digital Transformation in Health Care” is a two-day Harvard Medical School executive education program led by John D. Halamka and designed to provide you with the knowledge\, tools and strategies to design and implement technology-enabled change initiatives in health care. A certificate of completion will be offered for this program.
URL:https://www.masslifesciences.com/event/leading-digital-transformation-in-health-care/2020-05-14/
LOCATION:Harvard Medical School\, 25 Shattuck St\, Boston\, 02115\, United States
CATEGORIES:Other Upcoming Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200513T110000
DTEND;TZID=America/New_York:20200513T113000
DTSTAMP:20260406T084043
CREATED:20200311T205557Z
LAST-MODIFIED:20200311T205557Z
UID:11225-1589367600-1589369400@www.masslifesciences.com
SUMMARY:Harvard Medical School Executive Education Webinar: Natural Experiments in Health Care – What Really Works
DESCRIPTION:Join Anupam B. Jena\, MD\, PhD\, the Ruth L. Newhouse Associate Professor at Harvard Medical School\, for this webinar\, Wednesday\, May 13\, 11 AM. \nOne of the biggest challenges facing health care today is identifying what treatments and policy initiatives work and don’t work in real-world settings\, particularly when early evidence on treatment effectiveness stems from highly controlled\, small populations of patients and when treatments are costly. In this webinar\, Anupam B. Jena\, MD\, PhD\, the Ruth L. Newhouse Associate Professor at Harvard Medical School\, will discuss how natural experiments and big data can be used to inform our understanding of what works and doesn’t work in health care.
URL:https://www.masslifesciences.com/event/harvard-medical-school-executive-education-webinar-natural-experiments-in-health-care-what-really-works/
LOCATION:Harvard Medical School Webinar\, Online
CATEGORIES:Other Upcoming Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200428
DTEND;VALUE=DATE:20200501
DTSTAMP:20260406T084043
CREATED:20200221T035746Z
LAST-MODIFIED:20200311T211440Z
UID:10502-1588032000-1588291199@www.masslifesciences.com
SUMMARY:Driving Health Care Strategy: Insights from Inside the Ecosystem
DESCRIPTION:This Harvard Medical School Executive Education program is an intensive experience where participants learn from leading HMS faculty experts while networking with a cohort of professional peers. \nHealth care is being dramatically transformed by several converging forces. These include the accelerating growth of machine learning\, genomics and precision medicine\, digital technologies\, changes in reimbursement and a renewed focus on the patient at the center of care. Regardless of your role or the specific focus of your organization\, these forces will shape the challenges and opportunities for industry stakeholders across all health care sectors. Business and science leaders must operate at the complex intersection of these disruptions and possess a comprehensive understanding of the health care ecosystem. This is critical for their innovations to succeed and meet important unmet needs of patients\, providers or payers. Led by Dr. Stanley Shaw\, Associate Dean of Executive Education at Harvard Medical School\, this program will be taught by Harvard Medical School faculty who are leaders and distinguished innovators in their fields. Through their research and clinical practice\, they possess broad expertise and cutting-edge knowledge. A certificate of completion will be offered for this program.
URL:https://www.masslifesciences.com/event/driving-health-care-strategy-insights-from-inside-the-ecosystem/
LOCATION:Harvard Medical School\, 25 Shattuck St\, Boston\, 02115\, United States
CATEGORIES:Other Upcoming Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200408T123000
DTEND;TZID=America/New_York:20200408T130000
DTSTAMP:20260406T084043
CREATED:20200317T160746Z
LAST-MODIFIED:20200317T160746Z
UID:11361-1586349000-1586350800@www.masslifesciences.com
SUMMARY:Digital Health Apps: Evidence\, Reimbursement and Outcomes
DESCRIPTION:Apps for health\, wellness and disease management are increasingly common across the healthcare ecosystem. Health systems\, biotech and pharma\, payers and pharmacy benefits managers are just a few of the industry sectors actively using digital tools to try to improve care delivery and outcomes. \nThis Harvard Medical School executive education webinar will discuss emerging lessons and concepts from this space. What is the practical significance of the designation “digital therapeutic?” What are the current regulatory pathways? How does reimbursement actually work? Megan Jones Bell\, MD\, Chief Science Officer for Headspace\, will discuss examples of how these interventions are being integrated into health care and some of the developments on the horizon for this industry.
URL:https://www.masslifesciences.com/event/digital-health-apps-evidence-reimbursement-and-outcomes/
LOCATION:Harvard Medical School Webinar\, Online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200407
DTEND;VALUE=DATE:20200408
DTSTAMP:20260406T084043
CREATED:20200221T035745Z
LAST-MODIFIED:20200311T211225Z
UID:10500-1586217600-1586303999@www.masslifesciences.com
SUMMARY:HMX Pro - Immuno-oncology
DESCRIPTION:Join us for an online course that covers topics including tumor immunology\, checkpoint blockade therapy\, CAR T cell therapy\, and more. Applications are due by March 17. Course tuition is $800. \nHMX Pro online courses are designed to help busy professionals get up to speed on the latest advances in medical science. Each course is taught by Harvard Medical School faculty and include detailed animations and illustrations\, real-life scenarios\, and clinical videos that demonstrate the relevance of what you’re learning – with real patient interactions and cutting-edge treatments. Build your science knowledge and learn what’s behind today’s health care innovations – while having the opportunity to earn a certificate from Harvard Medical School. HMX Pro Immunology – Immuno-oncology is an advanced course that covers topics including tumor immunology\, checkpoint blockade therapy\, CAR T cell therapy\, and more. The next course period runs from April 7 – June 19\, 2020. Applications are due by March 17. Individual course tuition is $800.
URL:https://www.masslifesciences.com/event/hmx-pro-immuno-oncology/
LOCATION:Harvard Medical School Webinar\, Online
CATEGORIES:Other Upcoming Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200407
DTEND;VALUE=DATE:20200408
DTSTAMP:20260406T084043
CREATED:20200221T035745Z
LAST-MODIFIED:20200311T211218Z
UID:10499-1586217600-1586303999@www.masslifesciences.com
SUMMARY:HMX Pro - Cancer Genomics and Precision Oncology
DESCRIPTION:This online course from Harvard Medical School covers cancer mutations\, tumor sequencing\, cancer therapeutics\, and more. Applications are due by March 17. Individual course tuition is $800. \nHMX Pro online courses are designed to help busy professionals get up to speed on the latest advances in medical science. Each course is taught by Harvard Medical School faculty and include detailed animations and illustrations\, real-life scenarios\, and clinical videos that demonstrate the relevance of what you’re learning – with real patient interactions and cutting-edge treatments. Build your science knowledge and learn what’s behind today’s health care innovations – while having the opportunity to earn a certificate from Harvard Medical School. HMX Pro Genetics – Cancer Genomics and Precision Oncology is an advanced course that covers topics including cancer mutations\, tumor sequencing\, cancer therapeutics\, and more. The next course period runs from April 7 – June 19\, 2020. Applications are due by March 17. Individual course tuition is $800.
URL:https://www.masslifesciences.com/event/hmx-pro-cancer-genomics-and-precision-oncology/
LOCATION:Harvard Medical School Webinar\, Online
CATEGORIES:Other Upcoming Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200312T120000
DTEND;TZID=America/New_York:20200312T123000
DTSTAMP:20260406T084043
CREATED:20200221T035741Z
LAST-MODIFIED:20200311T210334Z
UID:10490-1584014400-1584016200@www.masslifesciences.com
SUMMARY:Harvard Medical School Executive Education Webinar: Genomics of Common Diseases: From Discovery to Translation
DESCRIPTION:In this webinar\, Dr. Sek Kathiresan will share his insights on the practical\, real-world translation of genomics for clinical practice and novel therapeutics development. \nFor common diseases of complex etiology such as myocardial infarction\, gene discovery studies have implicated causative genes and validated drug targets. Recently\, enthusiasm is growing for front-line applications of common disease genomics for clinical practice and therapeutics development. For instance\, polygenic risk scores (PRS) offer the potential to stratify disease susceptibility for broad populations at birth\, but strategies for clinical use are under active debate. Furthermore\, newer therapeutic modalities such as RNAi or genome editing raise the prospect of more rapid translation of genomic insights into therapies. Dr. Sek Kathiresan\, CEO of Verve Therapeutics and Professor of Medicine at Harvard Medical School (on leave)\, is a world-renowned pioneer in the genomics of cardiovascular disease. In this webinar\, he will share his insights on the practical\, real-world translation of genomics for clinical practice and novel therapeutics development.
URL:https://www.masslifesciences.com/event/harvard-medical-school-executive-education-webinar-genomics-of-common-diseases-from-discovery-to-translation/
LOCATION:Harvard Medical School Webinar\, Online
CATEGORIES:Other Upcoming Events
END:VEVENT
END:VCALENDAR